Contact lenses

Company officials cited lower prices and "overall softness" in demand for Cypher.

Sales of consumer products jumped 49 percent to $3.5 billion, as the brands acquired from Pfizer were absorbed by J&J and distributed around the world.

(Additional reporting by Lewis Krauskopf) © Reuters 2007.

All Rights Reserved.

< Previous 1 Next > Next Article: UPDATE 2-US Bancorp 1st-qtr profit falls 2 pct Industry View How does Johnson & Johnson compare to its industry peers?

P/E (12 mo.

trailing) Lower Price to Sales (12 mo.

trailing) Lower Dividend Yield Lower Sales Growth (12 mo.

trailing) Higher EPS (12 mo.

trailing) Higher ROI (12 mo.

trailing) Higher Find out more...

Industry News J&J handily beats forecast, shares jump Merck submits application for new Gardasil use Novartis says US OKs Reclast for bone disease More Industry News...

Most Viewed Business Articles Gates Foundation billions change pharma landscape Google says not encroaching on broadcasters ProLogis says to buy all units in Macquarie trust Top Company Searches on Reuters.com 1.

AAPL 2.

SIRI 3.

GOOG 4.

GE 5.

MSFT   6.

CSCO   7.

INTC   8.

GS   9.

SI.N 10.

MOT...

Read more...